Ipilimumab in a patient with known Crohn's disease: To give or not to give?

Journal of Crohn's and Colitis

Volumn 8, Issue 12, 2014, Pages 1742-

  Gielisse, Eric A R ^a   de Boer, Nanne K H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; ANTINEOPLASTIC AGENT; IPILIMUMAB; LOPERAMIDE; MONOCLONAL ANTIBODY;

ADULT; CASE REPORT; CHEMICALLY INDUCED; COLITIS; COMPLICATION; CROHN DISEASE; GASTROINTESTINAL ENDOSCOPY; HUMAN; MALE; MELANOMA; PATHOLOGY; SKIN NEOPLASMS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIDIARRHEALS; ANTINEOPLASTIC AGENTS; COLITIS; CROHN DISEASE; ENDOSCOPY, GASTROINTESTINAL; HUMANS; LOPERAMIDE; MALE; MELANOMA; SKIN NEOPLASMS;

EID: 84918517634     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.08.002     Document Type: Letter

References (3)

1. Hodi F.S., O'Day S.J., McDermott D.F., Weber R.W., Sosman J.A., Haanen J.B., et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010, 363:711-723.
2. Slangen R.M., van den Eertwegh A.J., van Bodegraven A.A., de Boer N.Kh. Diarrhoea in a patient with metastatic melanoma: ipilimumab ileocolitis treated with infliximab. World J Gastrointest Pharmacol Ther 2013, 4:80-82.
3. Beck K.E., Blansfield J.A., Tran K.Q., Feldman A.L., Hughes M.S., Royal R.E., et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol 2006, 24:2283-2289.